Related Experiment Videos
[Cholesterol reducing therapy--new aspects in stroke and diabetes]
1Institut für Klinische Chemie und Hämatologie, Kantonsspital, St. Gallen.
Schweizerische Medizinische Wochenschrift
|March 10, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.
Cancer chemotherapy and pharmacology·2010
Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2010
[Update of lipid lowering therapy].
Praxis·2008
Hypertriglyceridemia as a possible risk factor for prostate cancer.
Prostate cancer and prostatic diseases·2005
Short-term effects of atorvastatin on C-reactive protein.
European heart journal·2002
Comparability of serum and plasma concentrations of haemostasis activation markers.
Clinical chemistry and laboratory medicine·2001
Food group intake and chemotherapy-induced toxicity: a scoping review.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Intravenous Zoledronic Acid for Bone Pain Relief in Cancer Patients with Bone Metastasis Receiving Low Dose Opioids and Nsaids: A Randomized Controlled Study.
Journal of pain & palliative care pharmacotherapy·2026
Sequenced, Not Stirred: Positioning CAR T and Bispecific Antibody Therapy in Multiple Myeloma.
Blood cancer discovery·2026